Updated FDA Review Reiterates Risk of Bladder Cancer Associated with Actos

Posted by Firm Staff on Mar 3, 2017 4:01:18 PM

 

The FDA has released an updated safety review that links Actos use to an increased risk of bladder cancer. This warning was first made public in 2010, added to labels of pioglitazone-containing medicines in 2011, and was further confirmed through additional studies reviewed by the FDA in late 2016.

 

Read More

Topics: Health, Health News, Actos, Bladder Cancer, Actos Lawsuit, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Actos Attorney, Actos Lawyer, Actos Law

Contact Foster & Houston

More to Read